Relay Gross Profit from 2010 to 2024

RLAY Stock

USD 4.80 0.04 0.84%

Relay Therapeutics Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 14.9 M in 2024. Gross Profit is the profit Relay Therapeutics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

20.3 M

Current Value

14.9 M

Quarterly Volatility

21.6 M

Credit Downgrade

Yuan Drop

Covid

Check Relay Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Relay Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 32.6 M, Interest Income of 32.6 M or Depreciation And Amortization of 4 M, as well as many indicators such as Price To Sales Ratio of 50.19, Dividend Yield of 0.0 or PTB Ratio of 1.0. Relay financial statements analysis is a perfect complement when working with Relay Therapeutics Valuation or Volatility modules.

Check out the analysis of Relay Therapeutics Correlation against competitors.

For more information on how to buy Relay Stock please use our How to Invest in Relay Therapeutics guide.

Latest Relay Therapeutics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Relay Therapeutics over the last few years. Gross profit is a required income statement account that reflects total revenue of Relay Therapeutics minus its cost of goods sold. It is profit before Relay Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Relay Therapeutics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Relay Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.38 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Relay Gross Profit Regression Statistics

	Arithmetic Mean	5,476,648
	Geometric Mean	4,174,849
	Coefficient Of Variation	394.32
	Mean Deviation	13,041,970
	Median	(2,845,000)
	Standard Deviation	21,595,392
	Sample Variance	466.4T
	Range	82M
	R-Value	0.38
	Mean Square Error	428.9T
	R-Squared	0.15
	Significance	0.16
	Slope	1,845,757
	Total Sum of Squares	6529.1T

Relay Gross Profit History

	2024	14.9 M
	2023	20.3 M
	2022	-2.7 M
	2021	-896 K
	2020	79.1 M

Other Fundumenentals of Relay Therapeutics

Gross Profit Margin

Relay Therapeutics Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Net Receivables	Intangible Assets
Total Assets		0.99	0.95	0.67	-0.44	-0.85	0.9	0.92	-0.93	0.99	1.0	0.97	1.0	0.94	0.97	0.28	-0.88	-0.38
Total Stockholder Equity	0.99		0.96	0.65	-0.38	-0.84	0.87	0.92	-0.97	1.0	0.98	0.99	0.99	0.91	0.99	0.35	-0.84	-0.38
Net Tangible Assets	0.95	0.96		0.8	-0.16	-0.94	0.88	0.99	-0.98	0.96	0.94	0.97	0.94	0.88	0.97	0.33	-0.9	-0.63
Current Deferred Revenue	0.67	0.65	0.8		0.22	-0.91	0.8	0.86	-0.7	0.65	0.63	0.73	0.61	0.79	0.73	0.3	-0.78	-0.79
Net Debt	-0.44	-0.38	-0.16	0.22		-0.01	-0.18	-0.1	0.19	-0.38	-0.48	-0.27	-0.48	-0.33	-0.27	0.33	0.2	-0.49
Retained Earnings	-0.85	-0.84	-0.94	-0.91	-0.01		-0.91	-0.98	0.86	-0.84	-0.83	-0.9	-0.82	-0.86	-0.9	-0.25	0.96	0.75
Accounts Payable	0.9	0.87	0.88	0.8	-0.18	-0.91		0.91	-0.82	0.87	0.88	0.91	0.86	0.96	0.91	0.43	-0.91	-0.48
Capital Surpluse	0.92	0.92	0.99	0.86	-0.1	-0.98	0.91		-0.94	0.92	0.91	0.95	0.91	0.89	0.95	0.3	-0.94	-0.69
Total Liab	-0.93	-0.97	-0.98	-0.7	0.19	0.86	-0.82	-0.94		-0.97	-0.93	-0.96	-0.94	-0.83	-0.96	-0.41	0.81	0.53
Net Invested Capital	0.99	1.0	0.96	0.65	-0.38	-0.84	0.87	0.92	-0.97		0.98	0.99	0.99	0.91	0.99	0.35	-0.84	-0.38
Total Current Assets	1.0	0.98	0.94	0.63	-0.48	-0.83	0.88	0.91	-0.93	0.98		0.96	1.0	0.92	0.96	0.26	-0.87	-0.36
Capital Stock	0.97	0.99	0.97	0.73	-0.27	-0.9	0.91	0.95	-0.96	0.99	0.96		0.96	0.92	1.0	0.35	-0.88	-0.45
Net Working Capital	1.0	0.99	0.94	0.61	-0.48	-0.82	0.86	0.91	-0.94	0.99	1.0	0.96		0.9	0.96	0.26	-0.86	-0.36
Short Term Debt	0.94	0.91	0.88	0.79	-0.33	-0.86	0.96	0.89	-0.83	0.91	0.92	0.92	0.9		0.92	0.36	-0.85	-0.38
Common Stock	0.97	0.99	0.97	0.73	-0.27	-0.9	0.91	0.95	-0.96	0.99	0.96	1.0	0.96	0.92		0.35	-0.88	-0.45
Property Plant Equipment	0.28	0.35	0.33	0.3	0.33	-0.25	0.43	0.3	-0.41	0.35	0.26	0.35	0.26	0.36	0.35		-0.1	-0.14
Net Receivables	-0.88	-0.84	-0.9	-0.78	0.2	0.96	-0.91	-0.94	0.81	-0.84	-0.87	-0.88	-0.86	-0.85	-0.88	-0.1		0.64
Intangible Assets	-0.38	-0.38	-0.63	-0.79	-0.49	0.75	-0.48	-0.69	0.53	-0.38	-0.36	-0.45	-0.36	-0.38	-0.45	-0.14	0.64

Click cells to compare fundamentals

About Relay Therapeutics Financial Statements

Relay Therapeutics investors use historical fundamental indicators, such as Relay Therapeutics' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Relay Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	20.3 M	14.9 M
Gross Profit Margin	0.79	0.83

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Relay Stock Analysis

When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC